XML 120 R111.htm IDEA: XBRL DOCUMENT v3.21.2
Product and Geographic Sales Information - Adjusted EBITDA by Segment (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Sep. 30, 2021
Sep. 30, 2020
Segment Reporting Information [Line Items]                
Total Adjusted EBITDA $ 189,996     $ 108,207     $ 543,815 $ 286,548
Provision for income taxes (3,579)     (4,325)     (18,016) (13,693)
Depreciation and amortization (130,683)     (68,614)     (392,513) (176,200)
Interest, net (65,194)     (20,244)     (141,156) (72,306)
Deferred revenues adjustment (72)     (2,107)     (4,465) (7,421)
Transaction related costs (11,851)     (34,938)     1,599 (70,154)
Share-based compensation expense (11,997)     (6,796)     (38,518) (31,121)
Restructuring and impairment (15,621)     (3,192)     (121,988) (26,792)
Impairment of Long-Lived Assets to be Disposed of           $ (18,431)    
Other (10,700)     (5,224)     (24,817) (1,586)
Net loss 23,312 $ (82,210) $ (23,954) (181,986) $ (25,281) $ (129,633) (82,852) (336,900)
Fair Value Adjustment of Warrants 83,013     (144,753)     113,207 (224,175)
Net Income (Loss) Available to Common Stockholders, Basic 881     (181,986)     (105,283) (336,900)
Science Segment                
Segment Reporting Information [Line Items]                
Total Adjusted EBITDA 113,771     83,310     305,119 226,551
Intellectual Property Segment                
Segment Reporting Information [Line Items]                
Total Adjusted EBITDA $ 76,225     $ 24,897     $ 238,696 $ 59,997